文献速递乳腺乳腺X线

对比增强乳腺X线摄影中真阳性与假阳性表现的特征分析

Characterization of True and False Positive Findings on Contrast-Enhanced Mammography.
PubMed 文献 · Acad Radiol · 2022-02-18

该研究回顾性分析了2015年12月至2019年12月因诊断性对比增强乳腺X线摄影(CEM)推荐活检的160例病例共220个病灶,病例水平PPV2为58.1%。重组合成图像(RI)检出的病灶PPV2为40.8%,低于乳腺X线摄影/低能图像(MG)检出病灶的73.5%;假阳性100个中42个为RI检出。作者认为CEM的PPV2在其他诊断性乳腺影像检查范围内,但RI检出病灶的假阳性仍是挑战。

要点

  • RI检出病灶的PPV2为40.8%,低于MG检出病灶的73.5%,假阳性主要来自RI检出。
  • RI检出病灶中,肿块型PPV2最高(51.4%),局灶性强化最低(22.2%)。
  • MG检出病灶中,肿块型PPV2达83.8%,局灶性强化和非肿块强化分别为50%和54.1%。

核心结论

  • 诊断性CEM的PPV2在58.1%的病例水平,处于其他诊断性乳腺影像检查的范围内;但假阳性仍是挑战,尤其是RI检出的病灶,作者认为值得进一步努力提高RI检出病灶的特异度。

研究设计与样本

  • IRB批准的回顾性研究,纳入2015年12月至2019年12月期间推荐活检的诊断性CEM病例160例、病灶220个,采集背景实质强化、组织密度、病灶特征、病理/临床结局和检出方式,采用Pearson卡方检验和Fisher精确检验进行比较。

关键影像表现/征象

  • CEM包括类似标准二维乳腺X线摄影的低能图像(LE)和显示强化的重组合成图像(RI)。
  • MG检出病灶指在乳腺X线摄影或LE上识别的病灶,RI检出病灶指因RI上强化而识别的病灶。

诊断标准与关键数值

  • 病例水平PPV2为58.1%(160例)。
  • RI检出病灶占32.3%(71/220),其PPV2为40.8%;亚组分析局灶性强化PPV2为22.2%、非肿块强化为32%、肿块为51.4%。
  • MG检出病灶的PPV2为73.5%;亚组分析局灶性强化PPV2为50%、非肿块强化为54.1%、肿块为83.8%。
  • 假阳性病灶共100个,其中42个为RI检出。

临床应用与阅片要点

  • 解读CEM时需注意RI检出病灶的PPV2(40.8%)低于MG检出病灶(73.5%),RI检出病灶中局灶性强化PPV2最低(22.2%)。
  • 作者认为值得进一步努力提高RI检出病灶的特异度。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The purpose of this paper is to characterize true and false positive findings on contrast-enhanced mammography (CEM) and correlate enhancement pattern and method of detection with pathology outcomes.

MATERIALS AND METHODS: This was an IRB-approved retrospective review of diagnostic CEM performed from December 2015 through December 2019 for which biopsy was recommended. Background parenchymal enhancement, tissue density, finding features, pathologic/clinical outcomes, and method of detection were captured. CEM includes low-energy images (LE), similar to standard 2D mammography, and recombined images (RI) that show enhancement. 'MG-detected' findings were identified on mammography or LE. 'RI-detected' findings were identified due to enhancement on RI. The positive predictive value (PPV2) was calculated on a per-case and a per-finding level. Comparisons were performed using Pearson chi-square and Fisher exact tests.

RESULTS: One hundred sixty CEM cases with 220 findings were evaluated with a case PPV2 of 58.1%. 32.3% (71/220) of lesions were RI-detected. The PPV2 of RI-detected enhancement was 40.8% with subanalysis revealing PPV2 of 22.2%, 32%, and 51.4% for foci, NME, and masses, respectively. The PPV2 of MG-detected enhancement was 73.5% with subanalysis revealing PPV2 of 50%, 54.1%, and 83.8% for foci, NME, and masses, respectively. There were 100 false positives findings, 42 of which were RI-detected.

CONCLUSION: PPV2 of diagnostic CEM is within the range of other diagnostic breast imaging exams. However false positives remain a challenge, especially for RI-detected findings. Additional efforts to improve specificity of RI-detected findings are worthwhile.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Phillips, U Achibiri, Kim, et al. Characterization of True and False Positive Findings on Contrast-Enhanced Mammography. Acad Radiol. 2022. PMID: 35190261. doi:10.1016/j.acra.2022.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。